Skip to content
Review Open access

The Vitamin D-Gut-Brain Axis in Autism Spectrum Disorder: A Bidirectional Crosstalk

Sep 2026 · International Journal of General Medicine · Vol 19, pp. 1-21 · 0 citations · 225 references
Medicine

TL;DR

A narrative review that summarizes the current research progress regarding the association between vitamin D deficiency and gut microbiota dysbiosis in ASD and suggests future studies should focus on dissecting the underlying molecular crosstalk and developing personalized intervention strategies targeting vitamin D status and microbial signatures.

Abstract

Abstract Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder arising from the interaction of genetic and environmental triggers. In recent years, vitamin D deficiency and gut microbiota dysbiosis have emerged as two pivotal environment-related factors in ASD pathogenesis. Rather than acting independently, these factors jointly participate in the onset and progression of ASD through intricate bidirectional interaction mechanisms. This article presents a narrative review that summarizes the current research progress regarding the association between vitamin D deficiency and gut microbiota dysbiosis in ASD. Mechanistically, vitamin D modulates the gut-brain axis across multiple levels, including gut microbiota composition, intestinal barrier function, intestinal inflammation, bacterial translocation, microbial metabolites, blood-brain barrier integrity and neuroinflammation. In turn, the gut microbiota influences vitamin D metabolism and bioactivity through short-chain fatty acids, establishing a bidirectional vitamin D-gut-brain axis. This axis likely contributes to ASD phenotypes by regulating neuroinflammation, gut-brain crosstalk and neurodevelopmental processes. Notably, most available evidence in this field is derived from preclinical studies, while relevant clinical evidence remains limited. Future studies should focus on dissecting the underlying molecular crosstalk and developing personalized intervention strategies targeting vitamin D status and microbial signatures.

Read PDF

Similar papers

Review Open access Oct 2026

Gut microbiota–mediated tryptophan metabolic dysregulation in the comorbidity of inflammatory bowel disease and autism spectrum disorder: mechanisms and research progress

The “microbiota-gut-brain axis” represents a critical link connecting various aspects of intestinal physiology, brain function, and behavioral performance. Among these, tryptophan metabolism abnormalities mediated by gut microbes through the gut-brain axis (GBA) have garnered widespread attention in the study of IBD-AS...

Ming-Yu Lu, Yuxuan Chen, Heng-Li Zhou et al. · 0 citations
Review Open access Sep 2026

Research Progress on Bidirectional Regulation of the Microbiota–Gut–Brain Axis in Autism Spectrum Disorder Based on the Immune–Metabolic–Endocrine Interactive Network

Autism spectrum disorder (ASD) is a highly heterogeneous neurodevelopmental disorder characterized by core features of social communication deficits and high prevalence of gastrointestinal comorbidities. With its continuously rising global prevalence, current therapeutic modalities remain unable to target and ameliorat...

Wei-Ao Kong, Hao-Ke Qiu, Yu-Hang Jiang et al. · 0 citations
Open access Aug 2026

The gut microbiome as a modifiable contributor to autism spectrum disorder: a precision gut–immune–brain perspective

human observational studies, clinical trials, and mechanistic animal studies. Genetic susceptibility, early neurodevelopment, family environment, medications, restricted eating, and gastrointestinal symptoms may shape gut microbiome composition and function. Microbial communities may influence ASD-related traits throug...

Eva Sclabassi, J. Hur, Ji-Ying Ling et al. · 0 citations
Review Open access Sep 2026

THE GUT-BRAIN AXIS: EXPLORING THE IMPACT OF GUT MICROBIOTA ON MENTAL HEALTH

The microbiota-gut-brain axis represents a complex bidirectional communication network linking the intestinal microbiota with the central nervous system through neural, endocrine, immune, and metabolic pathways. Growing evidence suggests that alterations in gut microbiota composition may contribute to the pathophysiolo...

Agnieszka Kafara, Zuzanna Kafara, Julia Koronczok-Matusiak et al. · 0 citations
Review Open access Sep 2026

The Microbiota-Gut-Brain Axis in Disorders of Gut-Brain Interaction: Mechanisms and Emerging Therapeutic Strategies.

The authors analyze GBA dysfunction across major DGBIs subtypes (irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome), highlighting microbiota dysbiosis, barrier dysfunction, and central sensitization.

Cong Yu, Xiu-Juan Wang, Shu-Zhu Chen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.